Transarterial chemoembolization: the treatment, the evidence, and a patient’s experience

Hepatocellular carcinoma is a rare, yet devastating diagnosis with limited treatment options. For selected patients, transarterial chemoembolization (TACE) is a therapeutic choice which allows for treatment that is minimally-invasive, directed, and reduces mortality. Nonetheless, it represents an innovative approach to cancer treatment and investigating its efficacy from both a biomedical and biopsychosocial perspective warrant discussion